Skip to main content

JAKKS Pacific Reports Third Quarter 2025 Financial Results

Board approves Quarterly Cash Dividend SANTA MONICA, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — JAKKS Pacific, Inc. (NASDAQ: JAKK) today reported financial results for the third quarter ended September 30, 2025. Third Quarter 2025Net sales were $211.2 million, a year-over-year decrease of $110.4 million or 34%, driven largely by a reduction in direct-import sales due to a combination of customers anticipating lower consumer demand in response to tariff-driven price increases and the lack of new theatrical release-related product vs. prior yearUS net sales were $154.5 million, down 40% compared to Q3 2024 Rest of World net sales were $56.7 million, down 15% compared to Q3 2024Gross margin of 32.0% vs. 33.8% in Q3 2024, driven by US tariffs and higher royalty expense Gross profit of $67.6 million, down $41.2 million compared...

Continue reading

Stryker reports third quarter 2025 operating results

Portage, Michigan, Oct. 30, 2025 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) reported operating results for the third quarter of 2025: Third Quarter ResultsReported net sales increased 10.3% to $6.1 billion Organic net sales increased 9.5% Reported operating income margin of 18.7% Adjusted operating income margin(1) increased 90 bps to 25.6% Reported EPS increased 2.8% to $2.22 Adjusted EPS(1) increased 11.1% to $3.19  Third Quarter Net Sales Growth Overview  Reported   Foreign Currency Exchange   Constant Currency   Acquisitions / Divestitures   OrganicMedSurg and Neurotechnology         14.4         %           0.5         %           13.9         %           5.5         %           8.4         %Orthopaedics         3.9                     0.8                     3.1                     (8.3)            11.4          Total         10.3         %           0.7         %           9.6         %           0.1         %           9.5         %“We...

Continue reading

GSI Technology, Inc. Announces Second Quarter Fiscal 2026 Results

Closed $50 Million Financing to Fund Gemini-II Platform Completion and Commence Plato Chip Design SUNNYVALE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — GSI Technology, Inc. (Nasdaq: GSIT) today reported financial results for its second fiscal quarter ended September 30, 2025. Summary Comments for Second Quarter Fiscal Year 2026Revenue increased 3% sequentially and 42% year-over-year, fueled by strong market momentum for leading SRAM solutions; Quarter-end cash balance of $25.3 million, up from $13.4 million at the end of Q4 FY2025, including proceeds from the “at-the-market” (ATM) program; Subsequent to quarter-end, closed a registered direct offering for gross proceeds of $50 million; The Space Development Agency awarded an additional $752,000 under our existing SBIR to characterize our current Gemini-II die for radiation tolerance;...

Continue reading

Hub Group Reports Third Quarter 2025 Results

Highlights: GAAP diluted earnings per share (EPS) of $0.47 for the third quarter Third quarter revenue of $934 million Non-GAAP adjusted EPS of $0.49, which excludes adjusted items in the quarter Operating income of $39 million or 4.2% of revenue, adjusted operating income (non-GAAP) of $41 million or 4.4% of revenue Closed on the acquisitions of Marten Transport Intermodal assets and SITH, LLC Strong balance sheet with net debt/EBITDA LTM (non-GAAP) of 0.4x as of September 30, 2025OAK BROOK, Ill., Oct. 30, 2025 (GLOBE NEWSWIRE) — Hub Group, Inc. (Nasdaq: HUBG) announced third quarter 2025 net income of $29 million and diluted earnings per share of $0.47. Adjusting for certain expenses of $1.2 million (pre-tax), third quarter 2025 adjusted net income (non-GAAP) of $30 million decreased 6% from the prior year adjusted net...

Continue reading

SPX Reports Third Quarter 2025 Results

Raises Full-year Guidance CHARLOTTE, N.C., Oct. 30, 2025 (GLOBE NEWSWIRE) — SPX Technologies, Inc. (NYSE:SPXC) (“SPX”, the “Company”, “we” or “our”) today reported results for the third quarter ended September 27, 2025. Third Quarter Highlights (amounts presented for continuing operations; all comparisons against the third quarter of 2024, unless otherwise noted)Revenue of $592.8 million, up 22.6% GAAP income from continuing operations of $63.1 million, up 24.0% GAAP EPS of $1.29, up 19.4% Adjusted EPS* of $1.84, up 32.4% Adjusted EBITDA* of $136.1 million, up 30.9%Raising 2025 Guidance (all comparisons against the full year 2024, unless otherwise noted)Maintaining revenue range of $2.225 to $2.275 billion, up ~13% year-on-year at the midpoint. Adjusted EBITDA* range of $495 to $515 million, up ~20% year-on-year at the midpoint...

Continue reading

iRhythm Technologies Announces Third Quarter 2025 Financial Results

SAN FRANCISCO, Oct. 30, 2025 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended September 30, 2025. Third Quarter 2025 Financial HighlightsRevenue of $192.9 million, a 30.7% increase compared to third quarter 2024 Gross margin of 71.1%, a 230-basis point increase compared to third quarter 2024 Unrestricted cash, cash equivalents, and marketable securities of $565.2 million as of September 30, 2025 Increased fiscal year 2025 guidance for revenue and adjusted EBITDA marginRecent Operational HighlightsThird quarter 2025 record quarterly revenue driven by continued momentum in core long-term continuous monitoring business, sustained demand...

Continue reading

INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update

Company to Host Conference Call Today, October 30, at 4:30pm ET BOCA RATON, Fla., Oct. 30, 2025 (GLOBE NEWSWIRE) — INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announces its financial results for the quarter ended September 30, 2025 and provides a business update. Q3 2025 and Recent Corporate Highlights   CORDStrom™ Platform:Announced successful completion of first two commercial pilot-scale manufacturing runs of CORDStrom™ at CGT Catapult in preparation of regulatory filings to seek approval of CORDStrom™ for recessive dystrophic epidemolysis bullosa (RDEB). CORDStrom™ is on target to file an MAA submission mid-2026, followed shortly thereafter...

Continue reading

LLYC closes H1 2025 with growth across income, EBITDA, and profit

Operating income up 6.1% and recurring EBITDA up 15% Geopolitical uncertainty and market volatility present significant challenges to sustaining growth LLYC acquires a 60% stake in Digital Solvers in BrazilMADRID, Oct. 30, 2025 (GLOBE NEWSWIRE) — The audited results of LLYC (BME:LLYC) for the first half of 2025 confirm the key figures released in July. The global Marketing and Corporate Affairs consultancy posted operating income of €45.8 million, up 6.1% year over year, while total income (€64.8 million) reflected a slight 0.8% decline. Recurring EBITDA reached €7.9 million, a 15% increase, and net profit stood at €5.9 million. As of June 30, 2025, it reported €8.7 million in cash and €35.4 million in net financial debt, maintaining a Net Debt-to-EBITDA ratio of 1.9x. “The first half of the year brought significant challenges...

Continue reading

Vantiva – Third Quarter 2025 Revenues

Press Release Vantiva: Q3-2025 Revenues Up 7.9% Year-Over-Year Solid quarter boosted by pull-ahead demand, partially offset by foreign exchange impact Fourth quarter revenue levels are projected to be lower year-over-year due to customer timing Guidance maintained for 2025 at budget rate Paris, France – October 30, 2025 – Vantiva (Euronext Paris: VANTI), a global technology leader in connectivity, announces its unaudited revenues for the third quarter of 2025. Key Financial HighlightsRevenues were up 7.9% year-over-year (YOY) in the quarter despite a significant negative foreign exchange impact (+13.3% at constant rate). For the first 9 months, revenues increased by 7.9% YOY at actual rate and 10.8% at constant rate. The group maintains its guidance for the full year at the budget exchange rate (€/$ 1.05), assuming that component availability...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.